Population
Patients with neuroleptic malignant syndrome
Design
Review
Authors
Loading...
Proposed sympathetic model for NMS is hypothesis-generating; prospective validation needed before clinical adoption.
This paper proposes a comprehensive pathophysiological model suggesting that dysregulated sympathetic nervous system hyperactivity underlies neuroleptic malignant syndrome.
Ronald J. Gurrera (1999) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: